GlassScriptPhysician profile
Miguel Araneo
NPI 1053426783
$29,123.20
in general payments reported to CMS, 2019-2025
91 companies · $5,207 in 2025
The $5,207 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,555 · 2020: $2,690 · 2021: $3,513 · 2022: $4,244 · 2023: $4,371 · 2024: $5,542 · 2025: $5,207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $1,031 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,977.16 |
| Education | $1,030.66 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $113.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,610.54 | 2019-2025 | Opdivo, Krazati, Opdualag |
| Astrazeneca Pharmaceuticals LP | $1,597.31 | 2019-2025 | Tagrisso, Enhertu, Datroway |
| Merck Sharp & Dohme LLC | $1,497.29 | 2019-2025 | Keytruda, Lynparza, Reblozyl |
| Pfizer INC. | $1,468.34 | 2019-2025 | |
| Celgene Corporation | $1,295.45 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Sirtex Medical INC | $1,259.97 | 2019-2023 | Sir-Spheres Microspheres |
| Genzyme Corporation | $1,168.77 | 2019-2025 | |
| Incyte Corporation | $1,076.96 | 2019-2025 | Jakafi, Zynyz, Monjuvi |
| Novartis Pharmaceuticals Corporation | $1,039.45 | 2019-2025 | |
| Seagen INC. | $1,028.89 | 2019-2024 | Padcev, Tukysa, Tivdak |
| Astellas Pharma US INC | $939.36 | 2019-2025 | Xtandi, Vyloy, Xospata |
| Janssen Biotech, INC. | $874.98 | 2019-2025 | Tecvayli, Darzalex, Talvey |
| Exelixis INC. | $828.68 | 2019-2025 | Cabometyx |
| Tempus Ai, INC | $735.79 | 2024-2025 | Xt Cdx |
| Daiichi Sankyo INC. | $687.19 | 2019-2025 | Enhertu, Datroway |
Show all 91 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $680.84 | 2019-2025 | Polivy, Venclexta, Columvi |
| Abbvie INC. | $651.84 | 2019-2025 | Venclexta |
| Takeda Pharmaceuticals U.S.A., INC. | $569.55 | 2019-2025 | Alunbrig, Fruzaqla, Ninlaro |
| Glaxosmithkline, LLC. | $506.72 | 2020-2025 | Zejula, Jemperli, Ojjaara |
| Amgen INC. | $506.16 | 2019-2025 | Xgeva, Nplate, Lumakras |
| Lilly USA, LLC | $498.72 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Alexion Pharmaceuticals, INC. | $483.68 | 2019-2025 | Ultomiris, Soliris |
| Dova Pharmaceuticals | $460.65 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $456.88 | 2019-2025 | |
| Eisai INC. | $394.61 | 2019-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $385.45 | 2019-2023 | Imbruvica, Epkinly |
| Ipsen Biopharmaceuticals, INC | $320.84 | 2019-2025 | Onivyde, Somatuline Depot, Tazverik |
| Emd Serono, INC. | $301.83 | 2021-2025 | Bavencio, Tepmetko |
| Regeneron Healthcare Solutions, INC. | $297.65 | 2021-2025 | Libtayo, Lynozyfic |
| Novocure INC. | $297.43 | 2021-2025 | Optune Lua (Novottf-200t), Optune |
| Boehringer Ingelheim Pharmaceuticals, INC. | $294.72 | 2019-2025 | |
| Tersera Therapeutics LLC | $270.91 | 2023-2025 | Zoladex |
| Karyopharm Therapeutics INC. | $265.46 | 2020-2025 | Xpovio |
| Jazz Pharmaceuticals INC. | $238.69 | 2020-2025 | |
| Array Biopharma INC | $229.98 | 2022-2025 | Braftovi, Lorbrena, Mektovi |
| Rigel Pharmaceuticals, INC. | $203.21 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Foundation Medicine, INC. | $198.82 | 2022-2023 | |
| Adaptive Biotechnologies Corporation | $183.60 | 2022-2025 | Clonoseq |
| Tg Therapeutics, INC. | $163.06 | 2021-2022 | |
| Puma Biotechnology, INC. | $162.37 | 2019-2024 | |
| Mirati Therapeutics, INC. | $153.30 | 2023-2024 | Krazati |
| Beigene USA, INC. | $145.45 | 2022-2025 | Tevimbra, Brukinsa |
| Advanced Accelerator Applications | $141.42 | 2019-2020 | |
| G1 Therapeutics, INC. | $139.40 | 2022-2023 | Cosela |
| Deciphera Pharmaceuticals INC. | $129.83 | 2020-2025 | Qinlock |
| Kite Pharma, INC. | $125.26 | 2020-2025 | Yescarta |
| Sobi, INC | $120.90 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $111.33 | 2019-2025 | Xarelto |
| Global Blood Therapeutics, INC. | $102.86 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $99.95 | 2023 | |
| Mylan Institutional INC. | $92.01 | 2019-2022 | |
| Avyxa Pharma, LLC | $91.47 | 2025 | |
| Clovis Oncology, INC. | $89.29 | 2019-2022 | |
| Legend Biotech USA INC. | $88.21 | 2024-2025 | Carvykti |
| Alnylam Pharmaceuticals INC. | $76.87 | 2022-2024 | Givlaari |
| Geron Corporation | $73.95 | 2025 | Rytelo |
| Servier Pharmaceuticals LLC | $73.69 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $71.97 | 2019-2024 | |
| Coherus Oncology, INC. | $64.09 | 2020-2022 | |
| Pharmaessentia USA Corporation | $59.10 | 2022-2023 | Besremi |
| Apellis Pharmaceuticals, INC. | $56.96 | 2023-2024 | Empaveli |
| Caris Mpi, INC. | $56.83 | 2025 | Mi Cancer Seek |
| Octapharma USA, INC. | $55.26 | 2019-2022 | |
| Kyowa Kirin, INC. | $54.23 | 2024-2025 | Poteligeo |
| Taiho Oncology, INC. | $52.57 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $46.75 | 2021-2025 | Provenge |
| Azurity Pharmaceuticals, INC. | $43.25 | 2024 | Vivimusta |
| Blueprint Medicines Corporation | $38.94 | 2020-2021 | |
| Fennec Pharmaceuticals, INC. | $38.15 | 2024-2025 | Pedmark, Fyarro |
| Myovant Sciences INC. | $38.11 | 2021 | |
| Pharmacosmos Therapeutics INC. | $36.31 | 2022-2023 | Monoferric |
| Beone Medicines USA, INC. | $34.41 | 2025 | Tevimbra |
| Verastem, INC. | $34.06 | 2020-2025 | Avmapki Fakzynja Co-Pack |
| Helsinn Therapeutics (U.S.), INC. | $31.19 | 2019 | |
| Immunogen, INC. | $29.49 | 2023 | Elahere |
| Amneal Pharmaceuticals LLC | $27.86 | 2023 | Neulasta, Neupogen, Avastin |
| Stemline Therapeutics INC. | $25.15 | 2025 | Orserdu |
| Morphosys, US INC. | $21.63 | 2023 | Monjuvi |
| Apo-Pharma USA, INC. | $19.47 | 2019 | |
| Recordati_rare_diseases_inc. | $19.16 | 2024 | Sylvant |
| Cumberland Pharmaceuticals, INC. | $18.77 | 2025 | Sancuso |
| Gilead Sciences, INC. | $18.64 | 2022 | |
| Agios Pharmaceuticals, INC. | $18.60 | 2024 | |
| Ethicon INC. | $18.21 | 2020 | |
| Accord Healthcare, INC. | $17.34 | 2023 | |
| Emmaus Medical, INC. | $16.30 | 2019 | |
| Acceleron Pharma, INC. | $15.69 | 2021 | |
| Aveo Pharmaceuticals, INC. | $15.10 | 2021 | |
| Aurobindo Pharma USA, INC. | $14.62 | 2019 | |
| Celltrion USA INC. | $13.78 | 2025 | Vegzelma |
| Amag Pharmaceuticals, INC. | $13.38 | 2020 |
Drugs and devices associated with these payments
Xt Cdx $736Keytruda $735Sarclisa $610Xtandi $515Reblozyl $472Sir-Spheres Microspheres $456Enhertu $450Tecvayli $408Darzalex $383Opdivo $372Cabometyx $327Venclexta $313Lynparza $311Pomalyst $305Talzenna $290Zoladex $271Krazati $257Lenvima $250Imbruvica $237Orgovyx $226Kisqali $224Padcev $220Jakafi $210Jevtana $198Lorbrena $193Tavalisse $188Rezlidhia $188Carvykti $185Zejula $180Ultomiris $180Tukysa $176Xpovio $176Talvey $174Braftovi $173Mektovi $173Inlyta $172Jemperli $167Bosulif $165Tagrisso $161Ojjaara $158Pluvicto $158Datroway $154Optune Lua (Novottf-200t) $152Ibrance $146Elrexfio $144Onivyde $142Clonoseq $141Nubeqa $136Libtayo $134Rybrevant $133Tivdak $132Jaypirca $125Bavencio $120Xofigo $118Elahere $113Piqray $112Adcetris $104Polivy $103Alunbrig $103Soliris $99.99Verzenio $97.64Epkinly $96.93Cyclophosphamide $91.47Posfrea $91.47Axtle $91.47Docivyx $91.47Vyloy $91.45Tevimbra $89.67Oxbryta $82.07Erleada $80.36Fruzaqla $79.91Somatuline Depot $75.46Opdualag $74.23Rytelo $73.95Yescarta $72.57Qinlock $71.51Welireg $71.08Monjuvi $66.82Comirnaty $65.30Ninlaro $63.71Xospata $61.26Empaveli $56.96Mi Cancer Seek $56.83Fabhalta $54.96Poteligeo $54.23Keytruda Qlex $53.53Zynyz $53.10Gavreto $52.78Retevmo $50.89Givlaari $50.14Tazverik $48.57Doptelet $48.26Columvi $43.82Vivimusta $43.25Cerezyme $42.66Besponsa $42.63Paxlovid $41.49Brukinsa $39.38Scemblix $38.87Xalkori $38.52
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miguel Araneo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.